Cells, energy control and Parkinson’s: The role of PINK1 and Parkin

Dr. Miratul Muqit Abstract My research is directed at defining key pathways in cells that are linked to the development of Parkinson's and harnessing this knowledge to generate new ideas to prevent and treat the condition. Major advances in … [Continue reading]

Bench to bedside Parkinson’s Research

Dr. Esther Sammler Abstract The greatest unmet need in Parkinson’s are treatments that slow the relentless progression of its symptoms. The discovery of genetic changes in different genes that cause Parkinson’s have prompted new therapeutic … [Continue reading]

LRRK2 in Parkinson’s

Prof. Dario Alessi Abstract My laboratory is focused on deciphering the molecular causes of Parkinson’s. We believe that if we can comprehend what causes Parkinson’s, this will enable Researchers, Clinicians and Pharmaceutical Companies to work … [Continue reading]

Unveiling some mechanisms that trigger Parkinson’s

The loss of the brain's ability to produce dopamine is the cause of Parkinson's disease. 50 years ago levodopa was developed, which supplies the brain with the missing dopamine, and it is still the gold standard for treating Parkinson's. In order … [Continue reading]